IPF Research

See below for the latest in research news related to Idiopathic Pulmonary Fibrosis (IPF). This is where the PFF will share relevant news articles, press releases, and study results in the field of IPF. 

Capricor Therapeutics Announces U.S. FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19

Dec 15, 2020, 16:30 PM by Kelsey Overberg

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >